Login to Your Account

Pfizer Buying Into Perlegen's Pharmacogenomics Platform

By Karen Pihl-Carey

Wednesday, December 28, 2005
Taking 12 percent ownership in the firm, Pfizer Inc. invested $50 million in personalized medicine company Perlegen Sciences Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription